Therapeutic response to corticosteroids in a critically ill patient with COVID-19: A case report.
Medicine (Baltimore)
; 99(31): e21597, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: covidwho-696902
ABSTRACT
INTRODUCTION:
Since the coronavirus disease 2019 (COVID-19) outbreak in Wuhan in late 2019, controversy on the use of corticosteroids for COVID-19 has obtained increasing attention. We present 1 critically ill patient who had a rapid therapeutic response to moderate-dose corticosteroids. PATIENT CONCERNS A 53-year-old critically ill woman from Wuhan suffered with COVID-19. DIAGNOSIS The chest computed tomography scan was suggestive of COVID-19. The diagnosis was confirmed by a real-time reverse transcription polymerase chain reaction test for SARS-CoV-2. The critically ill status was characterized by worsening dyspnea, progressing bilateral lung consolidation, and poor oxygenation (SiO2/FiO2110âmm Hg).INTERVENTIONS:
The patient was treated with a moderate dose of intravenous corticosteroids and high-flow nasal cannula oxygen therapy.OUTCOMES:
After the initiation of corticosteroids, the patient rapidly improved over the following 6 days. Serial chest computed tomography scans showed good absorption of the consolidations. The patient was discharged on Day 17 of hospitalization without obvious adverse effects.CONCLUSIONS:
Early use of moderate-dose corticosteroids over a short period may enhance recovery from COVID-19 in critically ill patients.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Terapia por Inhalación de Oxígeno
/
Neumonía Viral
/
Corticoesteroides
/
Infecciones por Coronavirus
Tipo de estudio:
Reporte de caso
/
Estudio pronóstico
Límite:
Femenino
/
Humanos
/
Middle aged
Idioma:
Inglés
Revista:
Medicine (Baltimore)
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS